Reuters -- Cubist Pharmaceuticals Inc posted a quarterly profit that beat analysts’ expectations, helped by a 27 percent jump in U.S. sales of Cubicin, its antibiotic injection to treat bacterial infections.
Reuters -- Cubist Pharmaceuticals Inc posted a quarterly profit that beat analysts’ expectations, helped by a 27 percent jump in U.S. sales of Cubicin, its antibiotic injection to treat bacterial infections.
